Malik Fady Ibraham

Malik Fady Ibraham is listed in filings as EVP Research & Development at CYTOKINETICS INC. This profile follows SEC Form 4 activity through Jun 9, 2026, including sale activity. Recent filings connect the profile to CYTOKINETICS INC (CYTK) and Rocket Pharmaceuticals, Inc. (RCKT). The current snapshot covers public activity from Jun 20, 2024 to Jun 9, 2026. Reported amounts are shown as $237.9K to $547.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.